Psychotropic drug prescribing for people with intellectual disability

  • Research type

    Research Study

  • Full title

    Investigating decision making and choice in psychotropic drug prescribing for people with intellectual disability: qualitative study

  • IRAS ID

    225595

  • Contact name

    Angela Hassiotis

  • Contact email

    a.hassiotis@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Duration of Study in the UK

    0 years, 8 months, 31 days

  • Research summary

    This research is being conducted to improve the way that medication for mental health is used for people with intellectual disability. We are interested in the experiences and ideas of people with intellectual disability, family carers, and paid (staff) carers. We want to explore how people in these groups have been involved in decisions about medication and what could be done to improve their involvement and ensure that their voice is heard. We are interested in hearing from doctors who prescribe medication for mental health as we want to understand some of the difficulties and potential solutions for improving prescribing of these medicines.

    We also wish to seek the views of stakeholders on the design and content of an online tool for medication review known as the 'HealthTracker'.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    17/LO/1365

  • Date of REC Opinion

    19 Sep 2017

  • REC opinion

    Favourable Opinion